SCHEMBL29590784

SCHEMBL29590784

c1ccc2nc(-c3cn[nH]c3)cnc2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.59
▸ ILK Q13418 1/20 0.57
▸ AKT1 P31749 1/20 0.55
▸ AKT2 P31751 1/20 0.55
▸ NPC1 O15118 9/20 0.54
▸ RAB9A P51151 7/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ BCHE P06276 1/20 0.54
▸ KDM4E B2RXH2 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ FGFR1 P11362 3/20 0.51
▸ FGFR2 P21802 3/20 0.51
▸ FGFR3 P22607 3/20 0.51
▸ KDR P35968 3/20 0.51
▸ ALDH1A1 P00352 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ ADORA1 P30542 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5211835 1.00 MAPK1 (0.59) MAPK1ILKAKT1AKT2NPC1
SCHEMBL22092725 0.81 TGFBR1 (0.49) MAPK1ILKAKT1AKT2MAPT
SCHEMBL12178898 0.79 TLR9 (0.55) MAPK1NPC1RAB9AFGFR1FGFR2
SCHEMBL29400331 0.79 TLR9 (0.63) MAPK1ILKNPC1RAB9AFGFR1
SCHEMBL30646549 0.79 MAPK1 (0.52) MAPK1ILKBCHEMAPTFGFR1
SCHEMBL14833277 0.79 MAPK1 (0.52) MAPK1ILKAKT1AKT2FGFR1
SCHEMBL2592957 0.79 MAPK1 (0.52) MAPK1FGFR1FGFR2FGFR3KDR
SCHEMBL19749836 0.79 MAPK1 (0.52) MAPK1FGFR1FGFR2FGFR3KDR
SCHEMBL29590529 0.79 MAPK1 (0.52) MAPK1ILKAKT1AKT2FGFR1
SCHEMBL16642057 0.79 MAPK1 (0.52) MAPK1FGFR1FGFR2FGFR3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288426-A1 QUINOXALINE DERIVATIVES AND USES THEREOF Black Diamond Therapeutics, Inc. (US) 2023-12-13 — — EP disclosed
CN-117203202-A Quinoxaline derivative and use thereof 黑钻治疗公司 2023-12-08 — — CN disclosed
EP-4225749-A1 COMPOUNDS AND METHODS OF TREATING CANCERS Cullgen (Shanghai), Inc. (CN) 2023-08-16 — — EP disclosed
CN-116583509-A Compounds and methods for treating cancer 上海睿跃生物科技有限公司 2023-08-11 — — CN disclosed
WO-2022170122-A1 QUINOXALINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-08-11 — — WO disclosed
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 — — WO disclosed
Send feedback